TABLE 4.
Patient | Age (y) | Gender | Skin manifestations | Neurofibromas | Dysmorphic features | Skeletal manifestations | Ocular Manifestations | Neuropsychological manifestations | Other | References |
BUD | 14; 18 | N/A | CALs, F | Many CNF, SNF | Coarse face | SCS, genu valgum, joint laxity | N/A | SDiCD, ID, T2 hyperintensities | Many ST | Kehrer-Sawatzki et al., 2003 |
3724A | 13 | Female | CALs, F | Few CNF | Coarse face, FA, hypertelorism, ptosis, broad lips and nose | PE | LiN | Moderate ID | - | Cnossen et al., 1997 |
6 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Venturin et al., 2004a, b |
UWA106-3 | 18 | Male | CALs, F | Many CNF, PNF, spinal NF | Coarse face, large hands | MA | N/A | SDiCD, IQ 46 | Many ST | Dorschner et al., 2000; Kayes et al., 1992 |
442 | 18; 26 | Male | CALs, F | Multiple SCNF, and many CNF, PNF | Coarse face | SCS | LiN | IQ 76, severe LD | Many ST | Kehrer-Sawatzki et al., 2005 |
BL | 13,5 | Male | CALs, F | - | FD, hypertelorism | Skeletal anomalies | - | Severe ID | - | Riva et al., 2000 |
ID806 | 3 mo; 3; 4 | Male | CALs, F | - | Narrow palpebral fissures, ptosis, low set, rotated ears, prominent maxilla | - | - | Marked developmental delay, SP, seizure | - | Upadhyaya et al., 1996 |
UWA155-1 | 27 | N/A | - | Multiple CNF, spinal NF | Coarse face, ptosis, large hands and feet | MA | - | Moderate ID | MPNST | Dorschner et al., 2000 |
118 | 5 | Male | CALs, F | N/A | - | - | OPG | Seizure, no LD | - | Venturin et al., 2004b |
282775 | n.d. | N/A | CALs | - | Noonan-like FD | - | - | PD, SP | - | Mantripragada et al., 2006 |
552 | 20 | Female | CALs, F | 2 PNF, 4 SIN NF | Large hands and feet | PE, lumbar lordosis, pedes valgoplanus | LiN, visual disturbance | Mild ID, severe LD, SP, hypotonia | - | Kehrer-Sawatzki et al., 2008 |
NF040 | 1 | Female | CALs | PNF | - | - | * | * | - | Zhang et al., 2015 |
NF056 | 60 | Female | CALs, F | CNF | - | - | * | * | - | |
NF073 | 25 | Female | CALs, F | CNF | - | - | * | * | - | |
NF076 | 36 | Female | CALs | CNF | - | - | * | * | - | |
556/NF | 10 | Male | CALs, F | - | - | Bilateral PP | OPG | - | - | this study |
125/NF | 2 | Female | CALs, F | - | - | PE | - | - | - | |
134/NF | 40 | Female | CALs | SCNF | Hypertelorism | SCS | - | - | - | |
260/NF | 8 | Male | CALs, F | - | FD, hypertelorism | PE, MA | OPG | SDiCD, T2 hyperintensities | ASD |
CALs, café-au-lait spots; F, freckling; FA, facial asymmetry; FD, facial dysmorphy; CNF, cutaneous neurofibroma; SCNF, subcutaneous neurofibroma; PNF, plexiform neurofibroma; SIN NF, small intramuscular nodular neurofibroma; ST, spinal tumors; MPNST, malignant peripheral nerve sheath tumors; SDiCD, significant delay in cognitive development; ID, intellectual disability; LD, learning difficulties; SP, speech delay; PD, psychomotor delay; SCS, scoliosis; PE, pectus excavatum; MA, macrocephaly; PP, pes planus; LiN, Lisch nodule; ASD, atrial septal defect. * unclear results in the original article. NA, no data available.